Submitted by Anonymous (not verified) on 20 November 2023 - 10:57
Human medicines European public assessment report (EPAR): Leqvio, inclisiran, Hypercholesterolemia;Dyslipidemias, Date of authorisation: 09/12/2020, Revision: 5, Status: Authorised
Source: